These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16242100)

  • 1. [Selective serotonin reuptake inhibitors in childhood depression: a soap opera that reflects serious problems of drug safety].
    Peiró S; Cervera P; Bernal-Delgado E
    Gac Sanit; 2005; 19(5):401-6. PubMed ID: 16242100
    [No Abstract]   [Full Text] [Related]  

  • 2. Selective serotonin reuptake inhibitors in children with major depression.
    Blockman M
    S Afr Med J; 2006 Jun; 96(6):476-7; author reply 477-8. PubMed ID: 16841124
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comment. The role of regulatory agencies in the evaluation of drug safety: speaking about of selective serotonin receptor inhibitors].
    de Abajo FJ; Montero D; Calvo G
    Gac Sanit; 2005; 19(5):407-9. PubMed ID: 16242101
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of Selective Serotonin Re-uptake Inhibitors (SSRIs) in the treatment of depressive disorders in children and adolescents.
    James A
    Epidemiol Psichiatr Soc; 2005; 14(2):63-7. PubMed ID: 16001702
    [No Abstract]   [Full Text] [Related]  

  • 5. Antidepressants and adverse effects in young patients: uncovering the evidence.
    Herxheimer A; Mintzes B
    CMAJ; 2004 Feb; 170(4):487-9. PubMed ID: 14970096
    [No Abstract]   [Full Text] [Related]  

  • 6. [Administration of selective serotonin reuptake inhibitors (SSRI) for depression in children and adolescents].
    Fegert JM; Herpertz-Dahlmann B
    Nervenarzt; 2004 Sep; 75(9):908-10. PubMed ID: 15316621
    [No Abstract]   [Full Text] [Related]  

  • 7. [Intervention with selective serotonin reuptake inhibitors (SSRI) in depressed children and adolescents].
    Fegert JM; Herpertz-Dahlmann B
    Z Kinder Jugendpsychiatr Psychother; 2004 May; 32(2):74-5. PubMed ID: 15181782
    [No Abstract]   [Full Text] [Related]  

  • 8. Association between Selective Serotonin Reuptake Inhibitor Therapy and Suicidality: Analysis of U.S. Food and Drug Administration Adverse Event Reporting System Data.
    Umetsu R; Abe J; Ueda N; Kato Y; Matsui T; Nakayama Y; Kinosada Y; Nakamura M
    Biol Pharm Bull; 2015; 38(11):1689-99. PubMed ID: 26521821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Did regulators fail over selective serotonin reuptake inhibitors?
    Healy D
    BMJ; 2006 Jul; 333(7558):92-5. PubMed ID: 16825234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of suicide-related events through network analysis of adverse event reports.
    Nazir A; Ichinomiya T; Miyamura N; Sekiya Y; Kinosada Y
    Drug Saf; 2014 Aug; 37(8):609-16. PubMed ID: 24989167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The risk of suicidality with selective serotonin reuptake inhibitors.
    Mahendran R
    Ann Acad Med Singap; 2006 Feb; 35(2):96-9. PubMed ID: 16565762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of depression in children and adolescents: SSRI can/should be used after individual assessment].
    Melander H; Rastad JA
    Lakartidningen; 2007 Dec; 104(49-50):3798-800; discussion 3800. PubMed ID: 18214330
    [No Abstract]   [Full Text] [Related]  

  • 13. Proper studies of selective serotonin reuptake inhibitors are needed for youth with depression.
    Gibbons R; Mann JJ
    CMAJ; 2009 Feb; 180(3):270-1. PubMed ID: 19188617
    [No Abstract]   [Full Text] [Related]  

  • 14. [Selective serotonin reuptake inhibitors (SSRI's) are not indicated for children and adolescents with depression].
    Lekkerkerker JF; Schobben AF; van Dissel JT; Hekster YA; Hoes AW; Mulder GJ; Neef C; Peeters MF; van Ree JM; Rosmalen CF; Schellekens H; Schellens JH; Silberbusch J
    Ned Tijdschr Geneeskd; 2005 Aug; 149(33):1870-1; author reply 1871-2. PubMed ID: 16128186
    [No Abstract]   [Full Text] [Related]  

  • 15. Selective serotonin-reuptake inhibitors and suicidal ideation and behavior in children.
    Caballero J; Nahata MC
    Am J Health Syst Pharm; 2005 Apr; 62(8):864-7. PubMed ID: 15821279
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of selective serotonin reuptake inhibitors and youth suicide: making sense from a confusing story.
    Kutcher S; Gardner DM
    Curr Opin Psychiatry; 2008 Jan; 21(1):65-9. PubMed ID: 18281842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoxetine: new indication. Depression in children: too many uncertainties.
    Prescrire Int; 2008 Oct; 17(97):186-7. PubMed ID: 19534039
    [No Abstract]   [Full Text] [Related]  

  • 18. Selective serotonin reuptake inhibitors.
    Geddes JR; Cipriani A
    BMJ; 2004 Oct; 329(7470):809-10. PubMed ID: 15472236
    [No Abstract]   [Full Text] [Related]  

  • 19. Antidepressants and suicide: a commentary on a significant contribution to this debate.
    Goldney RD
    Crisis; 2005; 26(2):97-8. PubMed ID: 16138748
    [No Abstract]   [Full Text] [Related]  

  • 20. [Selective serotonin reuptake inhibitors (SSRI's) are not indicated for children and adolescents with depression].
    Treffers PD; Rinne-Albers MA
    Ned Tijdschr Geneeskd; 2005 Jun; 149(24):1314-7. PubMed ID: 16008032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.